{
    "organizations": [],
    "uuid": "ada7ee21b8031192e298610a5ee04bc6acf05d28",
    "author": "",
    "url": "https://www.reuters.com/article/brief-jazz-announces-fda-acceptance-of-n/brief-jazz-announces-fda-acceptance-of-nda-for-solriamfetol-for-excessive-sleepiness-associated-with-narcolepsy-or-obstructive-sleep-apnea-idUSASB0C8MC",
    "ord_in_thread": 0,
    "title": "BRIEF-Jazz Announces FDA Acceptance Of NDA For Solriamfetol For Excessive Sleepiness Associated With Narcolepsy Or Obstructive Sleep Apnea",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Market News March 2, 2018 / 1:44 PM / in 6 minutes BRIEF-Jazz Announces FDA Acceptance Of NDA For Solriamfetol For Excessive Sleepiness Associated With Narcolepsy Or Obstructive Sleep Apnea Reuters Staff 1 Min Read March 2 (Reuters) - Jazz Pharmaceuticals Plc: * JAZZ PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE OF NDA FOR SOLRIAMFETOL (JZP-110) FOR EXCESSIVE SLEEPINESS ASSOCIATED WITH NARCOLEPSY OR OBSTRUCTIVE SLEEP APNEA * JAZZ PHARMACEUTICALS PLC - SOLRIAMFETOL ‍PRESCRIPTION DRUG USER FEE ACT (PDUFA) GOAL DATE FOR AN FDA DECISION IS DECEMBER 20, 2018 ​ Source text for Eikon: Further company coverage:",
    "published": "2018-03-02T15:41:00.000+02:00",
    "crawled": "2018-03-02T15:54:21.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "market",
        "news",
        "march",
        "pm",
        "minute",
        "announces",
        "fda",
        "acceptance",
        "nda",
        "solriamfetol",
        "excessive",
        "sleepiness",
        "associated",
        "narcolepsy",
        "obstructive",
        "sleep",
        "apnea",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "jazz",
        "pharmaceutical",
        "plc",
        "jazz",
        "pharmaceutical",
        "announces",
        "fda",
        "acceptance",
        "nda",
        "solriamfetol",
        "excessive",
        "sleepiness",
        "associated",
        "narcolepsy",
        "obstructive",
        "sleep",
        "apnea",
        "jazz",
        "pharmaceutical",
        "plc",
        "solriamfetol",
        "drug",
        "user",
        "fee",
        "act",
        "pdufa",
        "goal",
        "date",
        "fda",
        "decision",
        "december",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}